Invacare Corporation (IVC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Invacare Corporation (IVC) trades at $0.66 with AI Score 42/100 (Grade C). Invacare Corporation designs, manufactures, and distributes medical equipment for home healthcare, retail, and extended care markets. Market cap: $24.91M, Sector: Healthcare.
Price live · AI analysis from May 10, 2026Analyst Coverage for IVC: IVC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IVC against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IVC: the 1 perspectives are evenly split.
How is this calculated? →Invacare Corporation (IVC) Healthcare & Pipeline Overview
Invacare Corporation, a global provider of medical equipment, focuses on mobility and lifestyle products, and respiratory solutions for home healthcare and extended care markets. With a history dating back to 1885, Invacare distributes through various channels, including retail, e-commerce, and direct sales, facing competition in a dynamic healthcare landscape.
What Is the Investment Thesis for IVC?
Invacare Corporation faces significant challenges despite its long history. With a market capitalization of approximately $0.02 billion and a negative profit margin of -13.6%, the company's financial performance raises concerns. The company operates in a competitive medical equipment market, requiring continuous innovation and efficient cost management. Upcoming catalysts include potential product launches and strategic partnerships to expand market reach. However, ongoing risks include fluctuating raw material costs and regulatory changes in the healthcare sector. Investors should closely monitor Invacare's ability to improve profitability and navigate industry headwinds.
Based on FMP financials and quantitative analysis
IVC Key Highlights
- Market capitalization of $24.91M, reflecting its small size within the medical equipment industry.
- Negative profit margin of -13.6%, indicating financial challenges and potential operational inefficiencies.
- Gross margin of 23.6%, suggesting some pricing power but also highlighting cost pressures.
- No dividend yield, indicating that the company is not currently returning capital to shareholders.
- Employs 3000 people, reflecting a significant operational footprint in the medical equipment manufacturing and distribution sector.
Who Are IVC's Competitors?
IVC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DHR Danaher Corporation | $193.75 | -2.11% | $137.13B | 69 |
| BSX Boston Scientific Corporation | $44.60 | -1.20% | 67B | 82 |
| ABT Abbott Laboratories | $95.28 | -0.13% | $165.95B | 70 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
| BLMHF Bloom Health Partners Inc. | $0.11 | +0.00% | $5.22M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IVC's Key Strengths?
- Established brand presence in the medical equipment market.
- Diverse product portfolio catering to various healthcare needs.
- Extensive distribution network.
- Long history in the industry (founded in 1885).
What Are IVC's Weaknesses?
- Negative profit margin indicating financial challenges.
- Small market capitalization compared to competitors.
- Dependence on specific product lines and markets.
- Potential vulnerability to changes in healthcare regulations.
What Could Drive IVC Stock Higher?
- Potential product launches in the mobility and respiratory segments.
- Strategic partnerships to expand market reach and product offerings.
- Restructuring initiatives to improve operational efficiency and reduce costs.
What Are the Key Risks for IVC?
- Financial-distress signal — its Altman Z-Score of 0.49 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-46.1%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Fluctuations in raw material costs affecting profitability.
- Changes in healthcare regulations and reimbursement policies impacting revenue.
- Intense competition from larger medical device companies.
- Negative profit margin and financial instability.
What Are the Growth Opportunities for IVC?
- Expansion of Respiratory Therapy Products: The market for respiratory therapy products is growing due to the increasing prevalence of respiratory diseases like COPD and asthma. Invacare can capitalize on this trend by expanding its Platinum and Perfecto2 oxygen concentrator lines, targeting both home and clinical settings. Strategic partnerships with respiratory clinics and home healthcare providers could facilitate market penetration. This segment represents a multi-billion dollar market with ongoing growth potential.
- Development of Advanced Mobility Solutions: With an aging global population, the demand for advanced mobility solutions, including power wheelchairs and seating systems, is expected to rise. Invacare can invest in R&D to develop innovative, user-friendly mobility products that cater to the specific needs of elderly and disabled individuals. Focusing on customization and integration with smart home technologies could provide a competitive edge. The market for mobility devices is projected to grow steadily over the next five years.
- Strategic Partnerships and Acquisitions: Invacare can pursue strategic partnerships or acquisitions to expand its product portfolio and geographic reach. Collaborating with companies specializing in complementary medical devices or assistive technologies can create synergistic opportunities. Expanding into emerging markets with high growth potential, such as Asia-Pacific and Latin America, can diversify revenue streams and reduce reliance on mature markets. These initiatives can be pursued on an ongoing basis.
- Enhancement of E-commerce and Direct-to-Consumer Sales: The shift towards online shopping provides an opportunity for Invacare to enhance its e-commerce platform and direct-to-consumer sales channels. Investing in user-friendly website design, targeted online marketing campaigns, and efficient order fulfillment processes can attract a wider customer base. Offering personalized product recommendations and online support services can improve customer satisfaction and loyalty. This is an ongoing opportunity to adapt to changing consumer behavior.
- Focus on Value-Added Services: Invacare can differentiate itself by offering value-added services such as equipment rentals, repair services, and external contracting. Providing comprehensive service packages can enhance customer relationships and generate recurring revenue streams. Investing in a skilled service team and efficient logistics infrastructure is crucial for delivering high-quality services. This ongoing focus on customer service can create a competitive advantage and strengthen brand reputation.
What Opportunities Does IVC Have?
- Expansion into emerging markets with growing healthcare needs.
- Development of innovative products and technologies.
- Strategic partnerships and acquisitions.
- Growing demand for home healthcare solutions.
What Threats Does IVC Face?
- Intense competition from larger medical device companies.
- Fluctuations in raw material costs.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns affecting healthcare spending.
What Are IVC's Competitive Advantages?
- Established brand recognition in the medical equipment market.
- Wide range of product offerings catering to various healthcare needs.
- Extensive distribution network reaching diverse customer segments.
What Does IVC Do?
Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio. The company designs, manufactures, distributes, and exports medical equipment used in home health care, retail, and extended care settings worldwide. Invacare's product portfolio includes mobility and seating products such as power wheelchairs under the Invacare TDX brand, custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names, and seating and positioning products under the Invacare brand. They also offer custom molded seat modules under the PinDot brand. The company's lifestyle products include pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands, safe patient handling products under the Birdie, Evo, and ISA brands, residential and institutional care beds and accessories, and manual wheelchairs under the Invacare brand. Additionally, Invacare provides respiratory therapy products, including stationary oxygen concentrators under the Platinum and Perfecto2 brands, portable oxygen concentrators under the Platinum brand, and Invacare HomeFill oxygen systems. Invacare serves home medical equipment providers through retail and e-commerce channels, as well as residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. The company also provides repair, equipment rentals, and external contracting services, and distributes heart rate monitors, thermometers, nebulizers, and portable ramps.
What Products and Services Does IVC Offer?
- Designs and manufactures mobility and seating products, including power and manual wheelchairs.
- Offers lifestyle products such as pressure relieving overlays and patient handling equipment.
- Provides respiratory therapy products, including stationary and portable oxygen concentrators.
- Distributes medical equipment for home health care, retail, and extended care markets.
- Sells products through retail, e-commerce, and direct sales channels.
- Offers repair, equipment rentals, and external contracting services.
How Does IVC Make Money?
- Designs, manufactures, and sells medical equipment.
- Generates revenue through product sales to home medical equipment providers, residential care operators, and government health services.
- Provides repair, rental, and contracting services for additional revenue.
What Industry Does IVC Operate In?
Invacare operates in the medical instruments and supplies industry, which is characterized by technological advancements, stringent regulations, and evolving patient needs. The global medical device market is projected to reach hundreds of billions of dollars by 2026, driven by an aging population and increasing prevalence of chronic diseases. Competition is intense, with major players and smaller innovative firms vying for market share. Invacare's position is challenged by its current financial performance, requiring strategic initiatives to regain competitiveness and capitalize on industry growth.
Who Are IVC's Key Customers?
- Home medical equipment providers.
- Residential care operators.
- Dealers and distributors.
- Government health service customers.
Invacare Corporation (IVC) Valuation Context
Valued at $24.91M, IVC is classified as a micro-cap stock. Relative to its peer group, IVC's quantitative score of 42/100 is below the peer average of 71/100.
ROE -46%Key Financial Metrics
Return on equity for Invacare Corporation stands at -46.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -13.1%, showing how much profit it generates from its asset base. A current ratio of 1.36 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 3/9Financial Health
Invacare Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.49 places it in the distress zone, a signal of elevated financial risk.
IVC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Established brand presence in the medical equipment market.
- Diverse product portfolio catering to various healthcare needs.
- Extensive distribution network.
- Long history in the industry (founded in 1885).
Bear Case
- Negative profit margin indicating financial challenges.
- Small market capitalization compared to competitors.
- Dependence on specific product lines and markets.
- Potential vulnerability to changes in healthcare regulations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
IVC Latest News
No recent news available for IVC.
IVC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IVC.
Price Targets
Wall Street price target analysis for IVC.
IVC MoonshotScore
What does this score mean?
The MoonshotScore rates IVC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Matthew E. Monaghan
CEO
Matthew E. Monaghan serves as the CEO of Invacare Corporation, leading a workforce of 3000 employees. His background includes extensive experience in the medical device and healthcare industries. Prior to joining Invacare, he held leadership positions at various healthcare companies, focusing on strategic planning, operational efficiency, and product innovation. He brings a wealth of knowledge in navigating complex regulatory environments and driving growth in competitive markets. His expertise is crucial for Invacare's turnaround efforts.
Track Record: Since assuming the role of CEO, Matthew E. Monaghan has focused on restructuring Invacare's operations and improving its financial performance. Key initiatives include streamlining the product portfolio, optimizing the supply chain, and expanding into new markets. While the company continues to face challenges, his leadership is aimed at stabilizing the business and positioning it for long-term growth. His strategic decisions are critical for Invacare's future.
IVC Healthcare Stock FAQ
What does Invacare Corporation do?
Invacare Corporation designs, manufactures, and distributes medical equipment for home healthcare, retail, and extended care markets worldwide. Its product range includes mobility and seating products like power wheelchairs and custom manual wheelchairs, lifestyle products such as pressure relieving overlays and patient handling equipment, and respiratory therapy products like oxygen concentrators. The company serves home medical equipment providers, residential care operators, and government health service customers through various channels, including retail, e-commerce, and direct sales.
What do analysts say about IVC stock?
Analyst coverage of Invacare Corporation (IVC) is limited, reflecting its small market capitalization and financial challenges. Consensus estimates suggest caution, with concerns about profitability and debt levels. Key valuation metrics indicate that the stock is highly speculative. Growth considerations include potential product launches and strategic partnerships, but risks remain due to intense competition and regulatory uncertainties. Investors should conduct thorough due diligence and consider their risk tolerance before investing in IVC.
What are the main risks for IVC?
Invacare Corporation faces several key risks, including intense competition from larger medical device companies, fluctuations in raw material costs affecting profitability, and changes in healthcare regulations and reimbursement policies impacting revenue. The company's negative profit margin and financial instability also pose significant challenges. Additionally, dependence on specific product lines and markets increases vulnerability to economic downturns and shifts in consumer preferences. Effective risk management and strategic adaptation are crucial for Invacare's survival and growth.
What are the key factors to evaluate for IVC?
Invacare Corporation (IVC) holds an AI score of 42/100 (low). Not financial advice.
How frequently does IVC data refresh on this page?
IVC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IVC's recent stock price performance?
Invacare Corporation (IVC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand presence in the medical equipment market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IVC overvalued or undervalued right now?
Valuing Invacare Corporation (IVC) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying IVC?
Before investing in Invacare Corporation (IVC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on publicly available information and may be subject to change.
- Analyst opinions may vary and should not be considered as investment advice.
- This dossier is for informational purposes only and does not constitute a recommendation to buy or sell securities.